Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the medical equipment provider’s ...

T2 Biosystems (NASDAQ:TTOO) Inc. shares have tumbled to a 52 ... This significant downturn reflects a staggering 1-year change, with the stock value eroding by nearly 95%. According to ...

Despite the delisting, T2 Biosystems' common stock is expected to begin trading on the OTC Markets system under the same trading symbol "TTOO" from the suspension date. T2 Biosystems does not plan ...

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of ...